Latest On Demand Webinars
Next-Generation Multiomics for Single-Cell and Spatial Profiling
Groundbreaking discoveries require innovative tools. Single-cell and spatial sequencing technologies have transformed our understanding of biology by letting us profile and visualize cell and tissue heterogeneity with powerful resolution.
Assembly and Annotation of Reference-Quality Human Genomes
With the development of long-read sequencing technology and improved computational methods, it is now possible for small teams of researchers to create reference-quality genome assemblies which will lead to a better understanding of the full spectrum of human genetic variation.
Getting a Gene Therapy Product to Market: Pitfalls and How to Prevent Them
Gene therapy is rapidly gaining importance as a critical treatment modality in the prevention or cure of a wide range of diseases. However, getting a product to market for commercial use does not come without its challenges.
Advanced Enzymes to facilitate SARS-CoV-2 Research
Research focused on SARS-CoV-2 has become a primary focus in genomic and molecular biology fields. The availability of accurate, efficient, and consistent analytical tools, including new methods for screening and studying virus-host interactions, is critical.
CRISPR Applications in Infectious Disease Research
As current events have demonstrated, infectious diseases represent a significant global concern. The ability for a novel infectious disease to appear and spread worldwide is greater now than at any time in our history.
Making Spatial Analysis Accessible to the Community
This talk will serve as a guide through on how the technology has evolved, how the protocol is run at NGI and the service that they provide their users.
Targeted Libraries and their Applications for Directed Evolution of Enzymes
Don’t miss this webinar illustrating the approach that Cellibre, a cellular agriculture company leveraged to significantly accelerate their Design.Build.Test cycles and engineer a key enzyme for cannabinoid production.
GMP Ancillary Materials for Cell and Gene Therapy Manufacturing
Ancillary materials (AMs), also called raw materials in Europe, are components, reagents, and materials used in the manufacturing of cell, gene, and tissue-engineered (CGT) therapies but are not intended to be present in the final product formulation.
A Successful Journey to Cell Therapy Manufacturing: From Research and Development to Lot-Release
Cell therapy is a transformative cancer treatment that utilizes genetically modified cells from a healthy donor or patient's own immune system to attack cancer cells, but manufacturing these cells represents a major challenge for the industry.
Racing Against Time: Rapid, High-Throughput Discovery of Antibody Therapeutics for SARS-CoV-2
Vanderbilt University Medical Center researchers Robert Carnahan and Pavlo Gilchuk are attempting to compress the timeline for therapeutic antibody development, by integrating a series of advances in single-cell messenger RNA sequence analysis, bioinformatics, synthetic biology and high-throughput functional analysis.